PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 184 filers reported holding PTC THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $23,278 | -20.1% | 572,353 | -4.8% | 0.33% | -21.4% |
Q1 2023 | $29,116 | +15.7% | 601,083 | -8.9% | 0.42% | +18.7% |
Q4 2022 | $25,175 | -99.9% | 659,540 | -9.9% | 0.36% | -29.9% |
Q3 2022 | $36,741,000 | +33.7% | 731,890 | +6.7% | 0.51% | +33.4% |
Q2 2022 | $27,477,000 | -13.2% | 685,900 | -19.2% | 0.38% | +7.9% |
Q1 2022 | $31,654,000 | -26.6% | 848,405 | -21.7% | 0.36% | -7.1% |
Q4 2021 | $43,132,000 | +2.6% | 1,082,905 | -4.2% | 0.38% | +4.1% |
Q3 2021 | $42,043,000 | -13.8% | 1,129,885 | -2.1% | 0.37% | -8.0% |
Q2 2021 | $48,770,000 | -0.7% | 1,153,785 | +11.2% | 0.40% | -5.2% |
Q1 2021 | $49,124,000 | -23.5% | 1,037,470 | -1.4% | 0.42% | -19.2% |
Q4 2020 | $64,196,000 | +18.2% | 1,051,868 | -9.4% | 0.52% | +2.6% |
Q3 2020 | $54,296,000 | +7.5% | 1,161,418 | +16.6% | 0.51% | +5.4% |
Q2 2020 | $50,522,000 | +22.0% | 995,695 | +7.3% | 0.48% | -2.4% |
Q1 2020 | $41,415,000 | +37.5% | 928,375 | +48.0% | 0.49% | +83.6% |
Q4 2019 | $30,128,000 | – | 627,270 | – | 0.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
RA Capital Management | 300,000 | $6,438,000 | 0.67% |
Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |